Alliance Global raised the firm’s price target on Fortress Biotech (FBIO) to $5 from $4.50 and keeps a Buy rating on the shares, citing increased value from its cash balance and Journey Medical (DERM) shares following the company’s Q1 report last week.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on FBIO: